Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease
Authors
Keywords
-
Journal
NEURON
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-10
DOI
10.1016/j.neuron.2022.08.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites
- (2022) Carlo Angeletti et al. iScience
- CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype
- (2022) Antoine Zélicourt et al. EMBO Molecular Medicine
- Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules
- (2022) Yun Shi et al. MOLECULAR CELL
- Multiple domain interfaces mediate SARM1 autoinhibition
- (2021) Chen Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
- (2021) Robert O. Hughes et al. Cell Reports
- Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross‐sectional study
- (2021) Delia Gagliardi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
- (2021) Matthew D. Figley et al. NEURON
- The Anatomical Distribution of Mechanoreceptors in Mouse Hind Paw Skin and the Influence of Integrin α1β1 on Meissner-Like Corpuscle Density in the Footpads
- (2021) Valerie Wai et al. Frontiers in Neuroanatomy
- Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
- (2021) Todd Bosanac et al. BRAIN
- Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD +
- (2021) Jureepon Roboon et al. JOURNAL OF NEUROCHEMISTRY
- Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate
- (2021) Wan Hua Li et al. eLife
- Neurofilaments in disease: what do we know?
- (2020) Brian A Gordon CURRENT OPINION IN NEUROBIOLOGY
- Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice
- (2020) Melissa B. Uccellini et al. Cell Reports
- Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1
- (2020) Matthew Bratkowski et al. Cell Reports
- Longitudinal biomarkers in amyotrophic lateral sclerosis
- (2020) Fen Huang et al. Annals of Clinical and Translational Neurology
- Diffuse axonal injury predicts neurodegeneration after moderate–severe traumatic brain injury
- (2020) Neil S N Graham et al. BRAIN
- The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative Sarm1
- (2020) Yuefeng Jiang et al. NATURE
- Direct pathogen-induced assembly of an NLR immune receptor complex to form a holoenzyme
- (2020) Shoucai Ma et al. SCIENCE
- Structure of the activated ROQ1 resistosome directly recognizing the pathogen effector XopQ
- (2020) Raoul Martin et al. SCIENCE
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination
- (2019) Jureepon Roboon et al. Frontiers in Cellular Neuroscience
- The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
- (2019) Kelly A. Hogan et al. Frontiers in Immunology
- NAD+ cleavage activity by animal and plant TIR domains in cell death pathways
- (2019) Shane Horsefield et al. SCIENCE
- Wallerian degeneration as a therapeutic target in traumatic brain injury
- (2019) Vassilis E. Koliatsos et al. CURRENT OPINION IN NEUROLOGY
- A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD + Decline
- (2018) Mariana G. Tarragó et al. Cell Metabolism
- TIR Domain Proteins Are an Ancient Family of NAD + -Consuming Enzymes
- (2018) Kow Essuman et al. CURRENT BIOLOGY
- Clarity reveals a more protracted temporal course of axon swelling and disconnection than previously described following traumatic brain injury
- (2018) Maura T. Weber et al. BRAIN PATHOLOGY
- Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis
- (2017) Rikke Maglemose et al. EXPERIMENTAL NEUROLOGY
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal Degeneration
- (2017) Kow Essuman et al. NEURON
- A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
- (2017) Yusuke Fukuda et al. Frontiers in Neuroscience
- Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
- (2016) Stefanie Geisler et al. BRAIN
- SARM1-specific motifs in the TIR domain enable NAD+loss and regulate injury-induced SARM1 activation
- (2016) Daniel W. Summers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis and Evaluation of Thiazoloquinolinones with Linkers To Enable Targeting of CD38
- (2016) Stephen S. Scully et al. ACS Medicinal Chemistry Letters
- Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38
- (2015) J. David Becherer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
- (2015) Curt D. Haffner et al. JOURNAL OF MEDICINAL CHEMISTRY
- How good are my data and what is the resolution?
- (2013) Philip R. Evans et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions
- (2013) J. Gerdts et al. JOURNAL OF NEUROSCIENCE
- dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
- (2012) J. M. Osterloh et al. SCIENCE
- Image-based Screening Identifies Novel Roles for IκB Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration
- (2011) Josiah Gerdts et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- LowModeMD—Implicit Low-Mode Velocity Filtering Applied to Conformational Search of Macrocycles and Protein Loops
- (2010) Paul Labute Journal of Chemical Information and Modeling
- electronic Ligand Builder and Optimization Workbench(eLBOW): a tool for ligand coordinate and restraint generation
- (2009) Nigel W. Moriarty et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide
- (2009) Y. Sasaki et al. JOURNAL OF NEUROSCIENCE
- KING (Kinemage, Next Generation): A versatile interactive molecular and scientific visualization program
- (2009) Vincent B. Chen et al. PROTEIN SCIENCE
- The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface area
- (2008) Paul Labute JOURNAL OF COMPUTATIONAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started